Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Phillips

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Cancer Research|December 16, 1998
Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programsR M Phillips, J Pearce, P M Loadman, et al.
Journal of Nursing Staff Development : JNSD|July 1, 1990
Collaborative education: the Dayton approachJ E Beavon, M B Brown, R L Landau, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2000
Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathyC C Evans, J R Pena, R M Phillips, et al.
Journal of Theoretical Biology|February 3, 2009
A mathematical model of doxorubicin penetration through multicellular layersC J Evans, R M Phillips, P F Jones, et al.
British Journal of Pharmacology|October 15, 2013
Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitorsM Ahmadi, Z Ahmadihosseini, S J Allison, et al.
Anti-Cancer Drug Design|April 3, 1998
5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitroM Jaffar, M A Naylor, N Robertson, et al.
Biochemical Pharmacology|February 29, 2000
The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positionsM P Saunders, M Jaffar, A V Patterson, et al.
Journal of Medicinal Chemistry|October 9, 1999
Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationshipsR M Phillips, M A Naylor, M Jaffar, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|June 28, 2013
Multidisciplinary guidelines for the care of late preterm infantsR M Phillips, M Goldstein, K Hougland, et al.
International Journal of Oncology|May 5, 2005
Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenograftsR E Airley, R M Phillips, A E Evans, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Cancer Research|December 16, 1998
Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programsR M Phillips, J Pearce, P M Loadman, et al.
Journal of Nursing Staff Development : JNSD|July 1, 1990
Collaborative education: the Dayton approachJ E Beavon, M B Brown, R L Landau, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2000
Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathyC C Evans, J R Pena, R M Phillips, et al.
Journal of Theoretical Biology|February 3, 2009
A mathematical model of doxorubicin penetration through multicellular layersC J Evans, R M Phillips, P F Jones, et al.
British Journal of Pharmacology|October 15, 2013
Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitorsM Ahmadi, Z Ahmadihosseini, S J Allison, et al.
Anti-Cancer Drug Design|April 3, 1998
5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitroM Jaffar, M A Naylor, N Robertson, et al.
Biochemical Pharmacology|February 29, 2000
The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positionsM P Saunders, M Jaffar, A V Patterson, et al.
Journal of Medicinal Chemistry|October 9, 1999
Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationshipsR M Phillips, M A Naylor, M Jaffar, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|June 28, 2013
Multidisciplinary guidelines for the care of late preterm infantsR M Phillips, M Goldstein, K Hougland, et al.
International Journal of Oncology|May 5, 2005
Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenograftsR E Airley, R M Phillips, A E Evans, et al.
Pageof 11